For example, somatic loss-of-function variants in STK11 are found in >20% of non-small cell lung cancer (NSCLC) patients, where they are associated with poorer prognosis and resistance to immunotherapy2,3. The gene discussed is STK11; the disease is non-small cell lung carcinoma.